Literature DB >> 8636435

Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin.

M C Daniels1, T P Ciaraldi, S Nikoulina, R R Henry, D A McClain.   

Abstract

We examined the activity of the rate-limiting enzyme for hexosamine biosynthesis, glutamine:fructose-6-phosphate amidotransferase (GFA) in human skeletal muscle cultures (HSMC), from 17 nondiabetic control and 13 subjects with non-insulin-dependent diabetes. GFA activity was assayed from HSMC treated with low (5 mM) or high (20 mM) glucose and low (22 pM) or high (30 microM) concentrations of insulin. In control subjects GFA activity decreased with increasing glucose disposal rate (r = -0.68, P < 0.025). In contrast, a positive correlation existed between GFA and glucose disposal in the diabetics (r = 0.86, P < 0.005). Increased GFA activity was also correlated with body mass index in controls but not diabetics. GFA activity was significantly stimulated by high glucose (22%), high insulin (43%), and their combination (61%). GFA activity and its regulation by glucose and insulin were not significantly different in diabetic HSMC. We conclude that glucose and insulin regulate GFA activity in skeletal muscle. More importantly, our results are consistent with a regulatory role for the hexosamine pathway in human glucose homeostasis. This relationship between hexosamine biosynthesis and the regulation of glucose metabolism is altered in non-insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636435      PMCID: PMC507176          DOI: 10.1172/JCI118538

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Neoplastic alterations of glucosamine 6-phosphate synthase in rat liver.

Authors:  S Tsuiki; T Miyagi
Journal:  Adv Enzyme Regul       Date:  1976

2.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

Authors:  A W Thorburn; B Gumbiner; F Bulacan; P Wallace; R R Henry
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Distribution of glutamine hexosephosphate aminotransferase in rat tissues; changes with state of differentiation.

Authors:  T C Richards; O Greengard
Journal:  Biochim Biophys Acta       Date:  1973-05-28

4.  Purification and some kinetic properties of rat liver glucosamine synthetase.

Authors:  P J Winterburn; C F Phelps
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

5.  Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine.

Authors:  R Kornfeld
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

6.  Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.

Authors:  T P Ciaraldi; L Abrams; S Nikoulina; S Mudaliar; R R Henry
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Glutamine fructose-6-phosphate aminotransferase and glycoprotein synthesis in the developing chick eye.

Authors:  A J Adler
Journal:  Curr Eye Res       Date:  1984-02       Impact factor: 2.424

8.  Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats.

Authors:  B Balkan; B E Dunning
Journal:  Diabetes       Date:  1994-10       Impact factor: 9.461

9.  Human glutamine: fructose-6-phosphate amidotransferase: characterization of mRNA and chromosomal assignment to 2p13.

Authors:  J Zhou; J L Neidigh; R Espinosa; M M LeBeau; D A McClain
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

10.  Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.

Authors:  R R Henry; L Abrams; S Nikoulina; T P Ciaraldi
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  12 in total

Review 1.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony.

Authors:  Mark A Herman; Barbara B Kahn
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 2.  Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.

Authors:  Yizhen Xu; Zhiheng He; George L King
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

3.  Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.

Authors:  Ping Huang; Shiuh-Rong Ho; Kai Wang; Bryan C Roessler; Fengxue Zhang; Yong Hu; Damon B Bowe; Jeffrey E Kudlow; Andrew J Paterson
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-22       Impact factor: 4.249

4.  Acute glucosamine-induced insulin resistance in muscle in vivo is associated with impaired capillary recruitment.

Authors:  M G Wallis; M E Smith; C M Kolka; L Zhang; S M Richards; S Rattigan; M G Clark
Journal:  Diabetologia       Date:  2005-07-30       Impact factor: 10.122

5.  High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.

Authors:  V Kolm-Litty; U Sauer; A Nerlich; R Lehmann; E D Schleicher
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 6.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.

Authors:  Gerald W Hart; Chad Slawson; Genaro Ramirez-Correa; Olof Lagerlof
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

7.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.

Authors:  Donald A McClain; William A Lubas; Robert C Cooksey; Mark Hazel; Glendon J Parker; Dona C Love; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

8.  Changes in the serum metabolite profile in obese children with weight loss.

Authors:  Thomas Reinehr; Barbara Wolters; Caroline Knop; Nina Lass; Christian Hellmuth; Ulrike Harder; Wolfgang Peissner; Simone Wahl; Harald Grallert; Jerzy Adamski; Thomas Illig; Cornelia Prehn; Zhonghao Yu; Rui Wang-Sattler; Berthold Koletzko
Journal:  Eur J Nutr       Date:  2014-04-17       Impact factor: 5.614

9.  Molecular convergence of hexosamine biosynthetic pathway and ER stress leading to insulin resistance in L6 skeletal muscle cells.

Authors:  V Srinivasan; U Tatu; V Mohan; M Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2009-04-16       Impact factor: 3.396

10.  Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2.

Authors:  Amber Lockridge; Seokwon Jo; Eric Gustafson; Niklas Damberg; Ramkumar Mohan; Miranda Olson; Juan E Abrahante; Emilyn U Alejandro
Journal:  Cell Rep       Date:  2020-05-05       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.